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 Cyanotis vaga (Lour.) Schult, & Schult. f. (C. vaga) previously called Tradescantia vaga 
and Cyanotis barbata, is an annual to perennial herb, belonging to the family Commelinaceae. It 
is native to Eastern Asia and Tropical Africa. Also, it is common in all types of forests, especially 
in pine forests, as well as in grassy areas. It has been reported that its decoction reduces fever and 
enhances well-being. Recently, C. vaga has been used widely for its anabolic effects, due to its 
richness of ecdysteroid compounds. Remarkably, all isolated compounds from C. vaga in this 
study are ecdysteroids. Even though C. vaga is a common medicinal plant, there are no reports 
about its effect on the drug metabolizing enzymes (cytochromes P450) to predict its interaction 
with concomitantly used medications. 
In this study, eight ecdysteroids were isolated from C. vaga, including two previously 
reported from C. vaga: 20-hydroxyecdysone (1) and rubrosterone (2). The additional six 
ecdysteroids were elucidated for the first time from C. vaga, and identified as 20-hydroxyecdysone 
2-acetate (3), 20-hydroxyecdysone 3-acetate (4), 2-doxyrubrosterone (5), poststerone (6), 
ajugasterone C (7) and dacryhainansterone (8). The plant extract and isolates were tested for their 
inhibitory effects on the CYP3A4 enzyme, which is a major CYP isoform involved in the 
metabolism of commonly-used clinical drugs. The extract showed strong inhibition of CYP3A4 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Natural Products Background 
 
The significance of natural products on human health issues is undeniable. Plant-based 
natural products represent 25% of all prescribed pharmaceuticals in industrialized countries. 
Moreover, flowering plants exclusively deliver 11% of the WHO’s list for primary and essential 
medications (Namdeo, 2007). Plant-based natural products, which are traditionally considered as 
secondary metabolites, are compounds that primarily do not contribute directly in either growth or 
development of the plant, and they may not have a recognized role in fundamental life processes. 
They are distributed and categorized among the plant kingdom in a way that shows distinct 
botanical taxonomy groups. However, primary metabolites (for example nucleotides, organic and 
amino acids) are present in all plants and play essential metabolic roles. Biosynthetic origins and 
chemical structures of primary and secondary metabolites share many similarities which make use 
them unhelpful to distinguish between metabolite categories. On the other hand, functionality can 
be a  valid distinction between primary metabolites, which contribute to nutrition, growth, and 
development, and secondary metabolites that are influenced by environmental interaction with 
plants (Croteau, Kutchan, & Lewis, 2000; Namdeo, 2007). In addition to numerous drugs, drug 
candidates and biological activities that secondary metabolites provide, plant-based natural 
products (secondary metabolites) are the most diverse category of dietary supplements. It is also 




 According to the Dietary Supplement Health and Education Act of 1994 (DSHEA), dietary 
supplements must state that the product is not intended to diagnose, treat, cure, or prevent any 
disease. Those include vitamins, minerals, amino acids, herbs or other botanicals, supplements that 
are used to increase total dietary intake, metabolites, extracts, or combinations of any ingredient 
described here (Health government, 1997; Newman & Cragg, 2007). The Act (DSHEA) enhanced 
the growth of herbal products as dietary supplements and limited the control of the Food and Drug 
Administration over them. As a result of this, the use of herbal remedies increased in the United 
States by 380% between 1990 and 1997 (Morris & Avorn, 2003). Obtaining herbal products from 
the internet is common, as it does not require healthcare provider approval (Owens, Baergen, & 
Puckett, 2014).  
In this study, an example of an online herbal dietary supplement, Cyanotis vaga, will be 
investigated phytochemically and will be tested for the possibility of interacting with 
concomitantly used medications. Through a quick online search on Cyanotis vaga, there are many 
products and different dosage forms available for this plant. The main users of C. vaga products 
are athletes, due to its ecdysteroids compounds. In this manuscript, C. vaga will be studied from 
different aspects in two chapters. The first chapter will cover C. vaga and ecdysteroids, in addition 
to the thesis objectives. The second chapter will take an in-depth approach to discuss C. vaga 









1.2 Overview of Cyanotis vaga 
 
 Cyanotis. vaga (Lour.) Schult & Schult.f., commonly known in India as Wondering Dew-
Grass, belongs to the Commelinaceae family, which has about 700 species under 50 genera broadly 
distributed in tropical and subtropical regions. C. vaga was called Tradescantia vaga from 1790 
to 1870 “TYPE: Cantona, China” then Cyanotis barbata from 1825 to 1894 “TYPE: Nepal” 
(Flowers of India, 2013; Nandikar & Gurav, 2014). According to The Plant List database, there 
are 16 different names, not including C. barbata, that are considered synonyms (The Plant List, 




Cyanotis vaga is an annual to perennial plant, rooting at the lower nodes allowing a new 
plant to rise with stems fully branched typically from the base, or distally, or few branched, 10-60 
cm. Leaves are on lateral branches with oval to lanceolate margins (10–15 × 0.5 cm, apex acute, 
base rounded, margin entire, serceous, leaf sheath 0.3–1 cm long). Flowers are bisexual, sepals 
oblanceolate to oblong (0.4–0.6 × 0.2 cm, pilose or glabrous; petals blue-purple or violet (Figure 










   



















Figure 1-2 Cyanotis vaga (Lour.) Schult. and Schult. f. A: Habit, B: Inflorescence, C: Flower, D: 
Stamen, E: Pistil, F: Capsule, G–H: Dorsal and ventral view of seed. Drawn by Mayur Nandikar 




1.2.2 Distribution  
 
  C. vaga has been a common species since the 19th century in Eastern Asia, which was 
described by Don (1825) as Cyanotis barbata D. Don. It is native to northeastern parts of India, 
Nepal, and Taiwan, in addition to Thailand and Vietnam. C. vaga is common in different types of 
forests, mainly in pine forests as well as in grassy areas. The flora of China also mentions C. vaga 
as a native Chinese plant (Tropicos.org., 2019). Furthermore, C. vaga’s scope of distribution 
extends to reach Tropical Africa and the Southwest of the Arabian Peninsula(Nandikar & Gurav, 
2014; Tropicos.org., 2019) (Figure 1-3). 
 
 
Figure 1-3 C.vaga distribution, Red color indicates native regions; eastern Asia, Tropical Africa, 







1.2.3 Medicinal uses and reported Biological activities  
 
It has been reported that C. vaga’s decoction reduces fever and enhances well-
being(Santos, Chua, Eufemio, & Abela, 1970). Also, its crude extract has shown antimutagenic 
effects(Gagalac-Nicolas & Lim-Sylianco, 1981). Several references, in 2006, 2015, and 2016 
showed extensive studies on C. vaga used in various formulae in Chinese medicines. C. vaga, 
mainly roots, has been used in those formulae along with other plants to treat several health 
conditions. Those conditions could be specific such as freckle removing(Tong & Li, 2016), 
postpartum perineal laceration, and tear scars prevention(C. Li, 2016; Su, 2016), treating femur 
head necrosis(Zhuang & Wang, 2016), viral myocarditis treatment(Bian, 2015), eyelashes edge 
inflammation treatment(Zhang, 2015), or a granule for treating anemia(Zhou, 2015). Other 
preparations indicate for dampness elimination and pain relieving(Lan, 2006), treatment of 
vasospasm in a spray form(Pang, 2015), and disinfectant for operating room(Wang, 2016) as well 
as a drug formulated for otitis media (D. Li, 2016). It has been published in patents for all of the 
previously listed conditions, and the amount of C. vaga and other plants to prepare the formulae 
differ from one another. Recently, C. vaga has been widely used for its anabolic effects due to the 
richness of its ecdysteroid compounds which have anabolic growth-stimulating activity on 
different in-vivo models such as mice, Japanese quails, and pigs. (Borrione, Luigi, Maffulli, & 
Pigozzi, 2008). Remarkably, all isolated compounds from C. vaga in this study are ecdysteroids. 
This class of secondary metabolites will be discussed in detail from several aspects in the next 







1.3 Ecdysteroids Class Overview   
 
 Ecdysteroids are secondary metabolites, found in different living organisms, known as 
insect molting hormones. Phytoecdysteroids refers to ecdysteroids obtained from plants, whereas 
Zooecdysteroids are isolated ecdysteroids from arthropods(Hetru & Horn, 1980). The discovery 
of ecdysteroids 65 years ago, led companies to invest millions of dollars in the 1980s, hoping to 
find a proper chemical pest control that came from a natural source, had a new biological target 
site and was safe for the environment. Ecdysteroids, arthropods’ steroid hormones, regulate 
molting, metamorphosis, and reproductive functions. They are, however, not anticipated to bind 
to the mammalian steroid receptors due to their slight chemical structure differences (Laurence 
Dinan, 1995; Lafont & Dinan, 2003). The presence of ecdysteroids in plants in large amounts, 
compared to very low yield in insects, increases the number of biological studies to investigate 
their effects and benefits on humans as well as animals(Chandrakala, Maribashetty, & Jyothi, 
1998).  
1.3.1 Chemical structure and biosynthesis  
 
 Ecdysteroids share some common chemical components. The backbone of ecdysteroids 
typically consists of 27, 28, or 29 carbons, and cannot be fewer than 19 carbons. Normally, they 
have a 7-en-6-one chromophore in ring B and a hydroxyl group at position 14. Also, the other 
characteristic feature is an A/B-cis ring fusion. Carbon 17 side chain usually controls the number 
of carbons in the structure. Hydroxylation of positions 1, 2, 3, 5, and 11 is common in addition to 
the main hydroxyl group at position 14. The free state of ecdysteroids is the dominant case; 





 The major biosynthetic pathways of plants’ ecdysteroids (phytoecdysteroids) have been 
proven. 20-hydroxyecdysone, the most abundant ecdysteroid compound in both insects and plants, 
is the main compound in the biosynthesis studies. These studies experimentally confirmed that the 
cholesterol is the precursor for phytoecdysteroid. The7-en-6-one chromophore arises along with 
the A/B-Cis ring fusion in the beginning steps of phytoecdysteroids biosynthesis. The next process 
is a hydroxylation at 14α position. The determination of other hydroxylations’ introduction order 
into the ecdysteroids backbone is not rigorously regulated as it can be different from plant to 
another(Baltaev, 2000; Davies, Lockley, Boid, Rees, & Goodwin, 1980)(Figure 1-4).  
 
Figure 1-4 cholesterol and 20-hydroxyecdysone structures 
 
1.3.2 Ecdysteroids in plants 
 
 The first ecdysteroid from plants was isolated in 1966, 12 years after the isolation of α-
ecdysone from pupae of silkworm(Butenandt & Karlson, 1954; Nakanishi, Koreeda, Sasaki, 
Chang, & Hsu, 1966). More than 500 ecdysteroid analogs have been reported between 1966 and 
2017(Lafont R., 2017). All plant parts – roots, stems, leaves, flowers, and seeds – contain 
phytoecdysteroids; however, the amount of them vary depending on the plant growing stage(L. 




hormones, they share many features with plant growth hormones, brassinosteroids. By contrast, 
phytoecdysteroids, in general, do not induce responses from the classical plant 
hormones(Gorelick-Feldman et al., 2008). The use of phytoecdysteroids on the hormonal level, 
mainly the growth and reproductions, is not totally approved. Nevertheless, a study on the level of 
20-hydroxyecdysone among different plants organs reveals that reproductive organs possess the 
highest level of 20-hydroxyecdysone, and the aerial parts accumulate the maximum amount of 
phytoecdysteroids during an intense growth period(Zibareva, 2000).  
 There is a robust amount of literature reporting the defense role of phytoecdysteroids in 
plants since they can defeat insect attacks on plants by acting as antifeedant substances, deterrent 
effects or endocrine-disrupting toxins(Bajguz & Dinan, 2004; L. Dinan, 2001; Soriano, Riley, 
Potter, & Bowers, 2004). Increasing the concentration of phytoecdysteroids is a proven strategy to 
rid an area of arthropods. Schmelz (1999) concluded that phytoecdysteroids concentration 
increased three fold in the root of Spinacia oleracea when it was exposed to root herbivory by 
Black Vine Weevil (BVW) larvae(Schmelz, Grebenok, Galbraith, & Bowers, 1999). Soriano 
(2004) showed the effect of elevated 20-hydroxyecdysone in Spinacia oleracea on four nematode 
species. Phytoecdysteroids, specifically 20-hydroxyecdysone, has protected the plant and led to 
molting abnormality, reduced invasion, and death of nematodes(Soriano et al., 2004).    
 
1.3.3 Therapeutic properties  
 
 Ecdysteroids have been investigated for biological activities since they were 
discovered(Burdette & Richards, 1961). The effects of ecdysteroids on mammalians are diverse 
and affect many bodily functions constructively(Bathori, Toth, Hunyadi, Marki, & Zador, 2008). 




mentioned most extensively in 2003 by Lafont R. and Dinan L(Lafont & Dinan, 2003). The most 
recent and brief review of ecdysteroids applications was done by Al Nagger et al. (2017) who 
summarized the pharmacological effects of ecdysteroids on physiological functions. Ecdysteroids 
have shown anabolic and adaptogenic activities, as well as hypoglycemic and hypocholesterolemic 
effects. Additional wound-healing and immuneprotectant abilities were demonstrated on mice, 
rats, and humans(Al Naggar, Ghorab, & Mohamed, 2017). Parr et al. (2015) carried out a study to 
investigate a hypothesis of estrogen receptor (ER) for ecdysteroids using in-silico modelling and 
to evaluate the anabolic in-vitro potency of ecdysteroids compared to other recognized anabolic 
chemicals and gave a suggestion about the consideration of ecdysteroids as prohibited substances 
of the World Anti-Doping Agency (WADA). She found that in-silico docking data of ecdysteroids’ 
anabolic activity is mediated through the estrogen receptor β- subtype. Also, her data showed that 
ecdysteroids’ anabolic potency were equal or higher than the anabolic androgenic steroids. Based 
on the high ecdysteroids anabolic potency in the rats, the author justified her suggestion to list 
ecdysteroids in the prohibited substances in the “S1 Anabolic Agents” category(Parr et al., 2015). 
According to the website of the World Anti-Doping Agency, a project was funded in 2016 to study 
the effects of ecdysteroids-containing products on human athletic performance(World Anti-









1.4 THESIS OBJECTIVES 
 
 Cyanotis vaga is a tremendous source of ecdysteroids. The anabolic effects of ecdysteroids 
increase the marketing of plants containing ecdysteroids as dietary supplements. The main focus 
of this study on ecdysteroid activities is due to their anabolic effect, which is the target of C. vaga 
consumers. Ecdysteroids do not bind to the androgen receptor (AR), which is the anabolic-
androgenic steroids binding site — the main lead of increasing muscle mass. This binding 
difference makes ecdysteroids an excellent anabolic alternative as they lack anabolic-androgenic 
steroids’ side effects, such as hepatotoxicity and behavioral changes(Bathori et al., 2008; Shahidi, 
2001).  
 In this study, eight compounds isolated from C. vaga were ecdysteroids. This class of 
natural products, as discussed earlier, possesses anabolic activity which makes C. vaga an 
excellent candidate to be an herbal dietary supplement, as a rich source of ecdysteroids. Dietary 
supplements’ advertisements demonstrate their potential benefits without revealing their side 
effects. Generally, herbs are assumed to be safe since they are natural. However, drugs and dietary 
supplements enter the body as foreign chemicals. They are metabolized mainly by cytochromes 
P450 enzymes. Vice versa, cytochromes P450 (CYP) enzymes are subjected to be induced or 
inhibited by drugs and dietary metabolites. There are 50 enzymes belonging to cytochrome P450. 
However, only six of them metabolize 90% of medications. CYP3A4 and CYP2D6 are the most 
significant isoforms(Lynch & Price, 2007).  
  Surprisingly, there are no reports about C. vaga effects on drug metabolizing enzymes, 
Cytochromes P450, to predict its interaction with concurrently administered medications. In this 
study, preliminary research of C. vaga’s safety profile will be conducted(Borrione et al., 2008). 




ecdysteroids content and examine its constituents along with the plant extract against one of the 




CHAPTER 2  
Isolation, Elucidation, and Drug Interaction Assay of C. vaga and its Chemical Constituent 
 
2.1 Introduction  
 
The aims of this study, as mentioned earlier, were to investigate C. vaga phytochemically 
and to examine the plant extract and its constituents against one of the primary metabolizing 
enzymes (CYP 3A4). The chemical constituent’s data available for C. vaga is very limited. First 
phytochemical study on C. vaga was done in 1970, and one ecdysteroid compound 
(Commisterone, currently called 20-hydroxyecdysone) was reported(Santos et al., 1970). Also, 
research groups in the Philippines worked on C. vaga in the 1970s and 1980s, and they reported 
two compounds. Another ecdysteroid compound (Rubrosterone), was isolated, in addition to a 
macrocyclic hydrocarbon(Abela & Santos, 1974; Chua, Santos, Abela, & Wagner, 1982).  There 
are no reports about C. vaga and its constituents in terms of safety, or on drug-herbal interaction 
specifically. This project is the first study that was conducted on C. vaga and its chemical 
constituents against cytochrome P450 (3A4 isoform).   
2.2 Experimental sections  
 
2.2.1 General experimental procedures 
 
NMR data were obtained on a Bruker 400 MHz and 500 MHz NMR spectrometers, 
whereas HR-ESI-MS spectra were recorded on an Agilent Series 1100 SL mass spectrometer. 




 Sephadex LH-20 (Sigma), and reversed-phase RP-C18 silica gel (Polarbond, JT Baker). 
TLC was checked under UV-254 nm, on aluminum-backed plates pre-coated with silica gel F254 
(20 × 20 cm, 200 μm, 60 Å, Merck), then visualized by spraying with (5:95) vanillin solution in 
concentrated H2SO4-EtOH (Sigma), and dried by heat gun. 
Recombinant human P450 3A4 (CYP3A4) was obtained from BD Gentest (Woburn, MA). 
Pooled human liver microsomes (HLM) prepared from 25 donors (total P450 concentration 0.320 
nmol mg-1 and protein concentration 20 mg mL-1) were bought from Corning Life Sciences 
(Cambridge, MA). 3-Cyano-7-ethox-ycoumarin (CEC), 7-methoxy-4-trifluoro-methylcoumarin 
(MEC), 7-benzyloxy-4-trifluoromethylcoumarin (BFC), ketoconazole and 0.5 M potassium 
phosphate buffer (pH 7.4) were from BD Gentest (Woburn, MA). NADPH regeneration solutions 
A and B were obtained from Corning Discovery Labware (Woburn, MA). Acetaminophen, 
testosterone, reduced glutathione (GSH), salicylamide, 6b-hydroxy-testosterone, magnesium 
chloride, phenacetin, and corticosterone were from Sigma-Aldrich (St Louis, MO). 
Troleandomycin was from Santa Cruz Biotechnology, Inc. (Dallas, TX). 
 
2.2.2 Plant material  
 
Whole Plant material of Cyanotis vaga was bought from Badmonkey Botanicals in 
September 2014 (www.badmonkeybotanicals.com), authenticated and registered at the National 
Center for Natural Products Research (NCNPR), School of Pharmacy at the University of 






2.2.3 Isolation and fractionation  
 
(10 g) of the whole plant (90% ethanol) extract was fractionated, and isolated by using 
different chromatographic stationary phases: silica gel 60 (230–400 mesh ASTM), silica gel 
reverse phase C-18, Sephadex LH-20 and eluted with different solvent systems which then affords 
eight ecdysteroids, some of them reported for the first time from this species. In particular, the 
plant material (10 g) was subjected to silica gel column chromatography (CC) using elution 
gradients (CHCl3-MeOH) starting with nonpolar toward polar gradients (10:0, 9.8:0.2, 9.5:0.5, 
9:1, and 8.5:1.5) then (EtOAc-MeOH-H2O), ratio (8:2:0.25), and finally 100% methanol, to give 
34 fractions (F-1 to F-34). Fraction F-9 (286 mg) was further separated by CC over silica gel 60 
(3cm x 118cm) eluted with (EtOAc-CHCl3-MeOH-H2O) (15:8:2:0.25) to obtain 6 sub-fractions 
F9A1 to F9A6. Compound 5 (2.2mg) was purified from sub-fraction F9-A2 by Reverse Phase C-
18 (3cm x 25cm) eluted with stepwise gradient of water-methanol (7:3, 6:4, 1:9). F15 was 
subjected to CC over Sephadex LH-20 (5cm x 70cm) to collect F15B1 to F15B5. Sub-fractions 
F15B2 and F15B3 then subjected to CC over silica gel 60 to afford compounds 3 (9.4mg) and 
compound 8 (40mg), however, sub-fraction F15B5 afforded compound 6 (13mg) through reverse 
phase C-18 CC experiment. Compounds 2 and 4 were obtained from F18 by repeated CC over 
silica gel 60 (2.5cm x 110cm), eluted with (EtOAc-CHCl3-MeOH-H2O) (15:8:4:1), followed by 
reverse phase C-18 (34cm x 2cm) eluted with stepwise gradient of H2O-MeOH (7.5:2.5, 6.5:3.5) 
to yield (10mg) of compound 2 and (8mg) of compound 4, respectively. Finally, F23 was subjected 
to CC over silica gel 60(3cm x 118cm), eluted with (15:8:2:0.25) (EtOAc-CHCl3-MeOH-H2O) 
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2.2.4  Cytochrome P 3A4 Inhibition assay 
 
The reversible inhibition of recombinant cytochrome P 3A4 was determined using 
Biological Fuel Cell (BFC) 10 mM, and assay conditions described earlier(Crespi, Miller, & 
Penman, 1997). Test sample and positive control were serially diluted in a solution (100 mL) of 
cofactors mix (1.3 mM NADP+, 66 mM MgCl2, and 66 mM G6P), control protein (15 mg ml-1) 
and glucose-6-phosphate dehydrogenase (40 Units mL1 in 5 mM sodium citrate buffer) to achieve 
six concentrations in the range of 100–0.4 mM or mg ml-1. After incubating at 37 °C  for 10 min, 
the plates were read to record the inherent fluorescence of the test compounds (if any). The reaction 
was started by the adding enzyme substrate mixture (100 µL), followed by incubation for 30 
minutes. The reaction was ended by adding 75 mL of ice-cold acetonitrile/0.5 M Tris base (80:20). 
Fluorescence was measured on Spectramax M5 plate reader (Molecular Devices, Sunnyvale, CA) 
at specified excitation and emission wavelength 409/530 nm for BFC/CYP3A4. IC50 values were 














2.3 Results and discussion  
 
2.3.1 Structures elucidation  
 
Structure elucidation of the isolated ecdysteroids (Figure 2-2) was accomplished by a 
combination of HR-ESI-MS and NMR data, in addition to the comparison of data from the 
literature. The compounds were identified as 20-hydroxyecdysone (1)(Budesinsky, Vokac, 
Harmatha, & Cvacka, 2008), Rubrosterone (2) (Tan, Wang, & Li, 2003) 20-hydroxyecdysone 2-
acetate (3), 20-hydroxyecdysone 3-acetate (4) (Budesinsky et al., 2008), 2-deoxyrubrosterone (5) 
(Sydykov & Segal, 1976), Poststerone (6) (Tan et al., 2003) Ajugasterone C (7) (Budesinsky et 
al., 2008), and Dacryhainansterone (8) (Girault et al., 1988).  
Previously reported compounds from C. vaga 
Previous phytochemical studies on C. vaga led to the isolation of two ecdysteroids, 20-
hydroxyecdysone (1)(Santos et al., 1970) and Rubrosterone (2)(Chua et al., 1982), in addition to a 
macrocyclic hydrocarbon(Abela & Santos, 1974). Compounds (1) and (2) have been isolated in 
this study. HR-ESI-MS spectrum, and 1D NMR experiments, 1H and 13C, have been conducted 
and the results were compared with literature data.  
First time reported compounds from C. vaga 
Even though compounds 3-8 are known compounds, this is the first time they are being 
reported from C. vaga. For their structure elucidations, 1D and 2D NMR experiments and HR-ESI-
MS spectra have been established in order to gain enough knowledge about their structures then 









Compound 1, 20-hydroxyecdysone, was obtained as a major compound. The molecular 
formula was confirmed as C27H44O7 based on the HR-ESI-MS spectrum(Figure 2-3 ) which gave 
an [M+HCOO]- ion at m/z 525.313 and an [M+Cl]- ion at m/z 515.284, in addition to an [2M]- ion 
at m/z 959.619 and [2M+Cl]- ion at m/z 995.596. Along with 13C NMR (Figure 2-4) which shows 
27 carbons resonances. 1H NMR spectrum (Figure 2-5), and other compound’s data are in 


































Figure 2-5 1H NMR spectrum of 1 in methanol-d4 
Compounds 2, Rubrosterone, has been reported from this plant previously. It has a 
molecular formula of C19H26O5, which was determined based on
13C NMR spectrum (Figure 2-7) 
and the HR-ESI-MS spectrum which gave deprotonated ions at m/z 335.187[M+H]+, m/z 
413.216[M+DMSO]+, and 691.348[2M+Na]+(Figure 2-6). From 1H NMR (Figure 2-8), the 
characteristic proton of C-7 at 5.91 was detected. Protons 3.97(1H, d), and 3.85(1H, dt) represent 
hydroxylated carbons in compound 2, beside C-14 which is dominated by a hydroxyl group in all 
isolated compounds. In accordance with DEPT-135, HSQC NMR spectra, the 19 carbons can be 
classified into two sp3 methyls, six sp3 methylenes, two sp3 methines, two sp3 oxygenated 

























Figure 2-7 13C NMR spectrum of  compound 2 in methanol-d4/CDCl3 
 
  




Compound 3, 20-hydroxyecdysone 2-acetate’s, molecular formula was determined as 
C29H46O8 from combined data of 
13C NMR (Figure 2-9) and protonated ions at m/z 545.310 
[M+Na]+ and 1067.629[2M+Na]+ in the HR-ESI-MS (Figure 2-10) 
 
 











Figure 2-10 Mass spectrum of compound 3 















In 1H NMR, the main difference feature than compound 1 is the singlet of (-OAc) at (2.08 
ppm) which is a highly deshielded methyl group compared to the others (Figure 2-11). 
 
 
Figure 2-11 1H NMR spectrum of 3 in methanol-d4 
             
 The carbon resonances (29 peaks) were classified into six sp3 methyls, eight sp3 
methylenes, three sp3 methines, three sp3 oxygenated methines, an sp2 methine, and seven non-
protonated carbons based on 13C, DEPT-135. Acetate position at C-2 was assigned in two steps, 
starting from matching 1D data of 1H and 13C through HSQC experiment (Figure 2-12) which 
then supported by the correlation of  H-H neighboring coupling from COSY experiment (Figure 
2-13) and that indicates two vicinal couplings between H-1α and H1β with H-2 which confirms 




range coupling between protons at position 19 and C-2 which also confirms C-2 acetate position 
(Figure 2-14).  
 
























Compound 4, 20-hydroxyecdysone 3-acetate, is also an acetate derivative of 20-
hydroxyecdysone, has the molecular formula of C29H46O8, based on 
13C NMR, 29 carbons 
resonances (Figure 2-15, Figure 2-16) and HR-ESI-MS spectrum which gave protonated ions at 

















Figure 2-16 13C NMR spectrum-B of  compound 4 in methanol-d4 
 
 




1H NMR of compound 4 shows protons 2 and 3 at (4.00 ppm, 5.17 ppm) respectively 
(Figure 2-18), followed by HSQC to correlate them with corresponding carbons (Figure 2-19), 
which indicates that position-3 is acetylated.  
 


































Compound 5, 2-deoxyrubrosterone, was obtained as a minor compound with very low yield 
(2.2mg). The molecular formula was determined as C19H26O4 according to DEPTQ-135 NMR 
spectrum (Figure 2-20), and the HR-ESI-MS spectrum gave deprotonated ions at m/z 353.157 
[M+Cl]-, and 363.186 [M+HCOO]- (Figure 2-21). 2-deoxyrubrosterone is similar to compound 2, 
rubrosterone, except that it has only two hydroxyl groups instead of three. In the HSQC 
experiment, only one oxygenated methine carbon appears at 70.08 ppm, along with a methine at  
53.81, position 5, correlating with 3.57 and 2.41 respectively (Figure 2-22).  
 











Figure 2-21 Mass spectrum of compound 5 
 
 





Poststerone, compound 6, is a 21 carbon ecdysteroids. The molecular formula, C21H30O5, 
was determined based on the 13C NMR spectrum(Figure 2-23), and the HR-ESI-MS spectrum 
which showed deprotonated ions at m/z 397.184 [M+Cl]-, and at m/z 407.212 [M+HCOO]- 
(Figure 2-25). 
 
Figure 2-23 13C NMR spectrum of  compound 6 in methanol-d4 
 
The 1H NMR spectrum shows a characteristic methyl group singlet of acetyl functional 
group 2.17 (3H) (Figure 2-24), which also has been detected in compound 2 and 3 as they both 







Figure 2-24 1H NMR spectrum of compound 6 in methanol-d4 
 
 




The 21 carbons resonances of compound 6 in 13C NMR spectrum were classified by 
support of DEPT-135 and HSQC NMR data into three sp3 methyls, six sp3 methylene, three sp3 
methines, two oxygenated methines, an sp2 methine, and six non-protonated carbons (Figure 2-26, 
Figure 2-27). 
 














Figure 2-27 HSQC-NMR spectrum of compound 6 in methanol-d4 
 





Compound 7, ajugasterone C, is the second major compound which also has 27 carbons 
and the same molecular formula of compound 1(20-hydroxyecdysone), C27H44O7. The molecular 
formula was obtained based on 13C NMR data of the molecule (Figure 2-30) and the HR-ESI-MS 
spectrum which gave an [M+HCOO]- ion at m/z 525.312 and an [M+Cl]- ion at m/z 515.283, in 
addition to an [2M+H]- ion at m/z 959.617, [2M+Cl]- ion at m/z 995.594, and [2M+HCOO]- ion 
at m/z1005.623 (Figure 2-31). The only difference between compound 1 and 7 is one hydroxyl 
group; In compound 1, C-25 is hydroxylated while C-11 is in compound 7. Protons 26 and 27 
usually appear as singlets due to the hydroxylation of C25; however, in compound 7, they show 
doublets as they coupled with proton 25 since it is not hydroxylated (Figure 2-29). 2D-NMR 
experiments HSQC (Figure 2-34), COSY (Figure 2-33), and HMBC clarify and support some 
overlapped data in the 1D-NMR spectra. 
 



















Figure 2-32 DEPT-135- NMR spectrum of  compound 7 in methanol-d4 
 






Figure 2-34 HSQC- NMR spectrum of compound 7 in methanol-d4 
 
 




Compound 8, Dacryhainansterone, is the only compound which has two double bonds 
among the isolated compounds. The molecular formula was obtained based on 13C NMR data of 
the molecule (Figure 2-37) and the HR-ESI-MS spectrum which gave a [M+H]+ ion at m/z 
463.306 (Figure 2-38). Proton NMR shows the same pattern of doublets for 26 and 27 due to their 
couplings with proton 25. Moreover, proton 18 overlapped with them (Figure 2-36). DEPT-135 
spectrum shows 20 resonances for all compound’s carbons except seven non-protonated carbons 
(Figure 2-39). 2D-NMR experiments HSQC (Figure 2-40), COSY (Figure 2-41), and HMBC 
(Figure 2-42) clarify and support some overlapped data in 1D-NMR.  
 

















Figure 2-39 DEPT-135 spectrum of  compound 8 in methanol-d4  
 
 





Figure 2-41 COSY-NMR  spectrum of compound 8 in methanol-d4 
 




2.3.2 CYP inhibition activity     
 
C. vaga and all of its isolated compounds in this study (except compound 5) were tested 
against Cytochrome P450 (3A4 isoform) – which is one of the most significant drug metabolizing 
enzymes.  The plant extract showed strong inhibition of CYP (3A4) with an IC50 value of 8.5 μg/ml 
while 20-hydroxyecdysone and ajugasterone C, the major compounds, did not show inhibition of 
CYP (3A4). Compounds 2, 3, and 8 showed moderate inhibitions whereas 4 and 6 did not show 
any inhibition for CYP3A4 at all (Figure 2-44). No inhibition test was carried out for compound 
5 because of its low yield (2.2mg). The concentration response curve of compounds 2, 3, 8, and 
the plant extract shows the inhibition in a concentration-dependent way (Figure 2-43).  The IC50 
values of active samples were (75 + 10), (41.5 + 8.5), (85 + 10), (8.5 + 0.0) µg/ml, for compounds 
2, 3, 8, and the extract, respectively.  
Overall, this finding of C. vaga’s capability, to inhibit CYP (3A4) – one of the essential 
isoforms among Cytochrome P 450 enzymes – is an essential indicator for actual drug-herbal 
interaction. Further studies should be conducted on C. vaga and other significant Cytochrome P 
isoforms should be included. Also, these results reveal a strong inhibition activity of the plant 
extract with a big gap relative to the activity of  its constituents. That may express the presence of 
other chemical compounds that were not isolated in this study, or the isolated compounds together 
could possesssynergic inhibition effects— which lead to an increase in the plant extract inhibitory 









Figure 2-43 Concentration Response Curve 
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